For patient C26, we sequenced 4 areas of the primary tumor and noted concordance for mutations for TP53 from 3 parts of the tumor and corresponding CTCs, suggesting that tumor heterogeneity likely plays a role in CTC shedding (Figure S8). This evidence concerns the gene TP53 and neoplasm.